Inventage Lab Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Public

  • Employees
  • 69

Employees

  • Stock Symbol
  • 389470

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $15.14
  • (As of Friday Closing)

Inventage Lab General Information

Description

Inventage Lab Inc operates medical technology development businesses. The company engages in the development of an Drug Delivery System (DDS). It has developed Laminar FluiDigm, a microfluidics-based novel platform technology that builds the foundation for IVL- DrugFluidic and IVL-GeneFluidic, which are specific platform technologies used for developing and manufacturing long-acting injectables and gene-delivery therapeutics.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Urim Lions Valley III, Units 101, 601, 612, 24
  • Dunchon-daero 388beon-gil, Jungwon-gu
  • Seongnam, Gyeonggi 13403
  • South Korea
+82
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Drug Delivery
Stock Exchange
KRX
Vertical(s)
Corporate Office
  • Urim Lions Valley III, Units 101, 601, 612, 24
  • Dunchon-daero 388beon-gil, Jungwon-gu
  • Seongnam, Gyeonggi 13403
  • South Korea
+82

Inventage Lab Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Inventage Lab Stock Performance

As of 13-Nov-2026, Inventage Lab’s stock price is $15.14. Its current market cap is $201M with 13.3M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$15.14 $15.45 $14.03 - $69.66 $201M 13.3M 79.2K -$0.18

Inventage Lab Financials Summary

As of 30-Jun-2026, Inventage Lab has a trailing 12-month revenue of $1.7M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 294,757 736,262 124,316 101,544
Revenue 1,704 2,065 1,307 503
EBITDA 576 (1,811) (10,214) (18,617)
Net Income (2,164) (5,943) (12,457) (20,646)
Total Assets 125,818 76,834 49,053 35,061
Total Debt 22,554 14,224 11,066 8,314
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Inventage Lab Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Inventage Lab‘s full profile, request access.

Request a free trial

Inventage Lab Patents

Inventage Lab Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026187051-A1 Lipid nanoparticle preparation device to which inline dilution channel is applied, and lipid nanoparticle preparation method using same Pending 06-Mar-2025
CA-235431-S Apparatus for manufacturing lipid nanoparticles Active 30-May-2024
WO-2025244348-A1 Microparticles comprising orforglipron or pharmaceutically acceptable salt thereof, and method for preparing same Pending 20-May-2024
CA-232154-S Lipid nanoparticle manufacturing device Active 15-Feb-2024
US-D1140080-S1 Lipid nanoparticle preparation device Active 15-Feb-2024
To view Inventage Lab’s complete patent history, request access »

Inventage Lab Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Inventage Lab Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Inventage Lab‘s full profile, request access.

Request a free trial

Inventage Lab Investments (3)

Inventage Lab’s most recent deal was a PIPE with Quratis for . The deal was made on 16-Mar-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Quratis 16-Mar-2026 PIPE Drug Discovery
Quratis 12-Mar-2025 PIPE Drug Discovery
Curatis Holding 31-Jan-2025 PIPE Pharmaceuticals
To view Inventage Lab’s complete investments history, request access »

Inventage Lab ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Commercial Services

Industry

Rank

Percentile

Business Support Services

Subindustry

Rank

Percentile

To view Inventage Lab’s complete esg history, request access »

Inventage Lab FAQs

  • When was Inventage Lab founded?

    Inventage Lab was founded in 2015.

  • Where is Inventage Lab headquartered?

    Inventage Lab is headquartered in Seongnam, South Korea.

  • What is the size of Inventage Lab?

    Inventage Lab has 69 total employees.

  • What industry is Inventage Lab in?

    Inventage Lab’s primary industry is Pharmaceuticals.

  • Is Inventage Lab a private or public company?

    Inventage Lab is a Public company.

  • What is Inventage Lab’s stock symbol?

    The ticker symbol for Inventage Lab is 389470.

  • What is the current stock price of Inventage Lab?

    As of 13-Nov-2026 the stock price of Inventage Lab is $15.14.

  • What is the current market cap of Inventage Lab?

    The current market capitalization of Inventage Lab is $201M.

  • What is Inventage Lab’s current revenue?

    The trailing twelve month revenue for Inventage Lab is $1.7M.

  • What is Inventage Lab’s annual earnings per share (EPS)?

    Inventage Lab’s EPS for 12 months was -$0.18.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process